Trial Profile
Practical daily effectiveness and tolerance of Procoralan in chronic systolic heart failure in Germany.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2015
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Chronic heart failure
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Acronyms INTENSIFY
- Sponsors Servier
- 31 Dec 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 22 Jun 2012 New trial record